Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $22,123 - $29,407
-308 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$67.0 - $84.39 $3,484 - $4,388
-52 Reduced 14.44%
308 $23,000
Q3 2020

Nov 12, 2020

SELL
$55.23 - $79.93 $454,321 - $657,504
-8,226 Reduced 95.81%
360 $28,000
Q2 2020

Aug 11, 2020

BUY
$30.2 - $56.98 $93,529 - $176,467
3,097 Added 56.42%
8,586 $477,000
Q1 2020

May 08, 2020

SELL
$24.87 - $38.56 $529,059 - $820,286
-21,273 Reduced 79.49%
5,489 $163,000
Q4 2019

Feb 12, 2020

BUY
$25.43 - $36.67 $665,909 - $960,240
26,186 Added 4546.18%
26,762 $969,000
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $5,750 - $6,992
-250 Reduced 30.27%
576 $16,000
Q2 2019

Jul 30, 2019

BUY
$22.81 - $28.48 $18,841 - $23,524
826 New
826 $20,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.